Acadian Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,756,129	Closed	-$19.3M	–	1640
2017 Q2	$19.3M	Sell	1,756,129 -26,610	-1%	-$266K	0.09%	209
2017 Q1	$17.5M	Sell	1,782,739 -136,433	-7%	-$1.36M	0.08%	218
2016 Q4	$20.7M	Sell	1,919,172 -65,850	-3%	-$658K	0.1%	189
2016 Q3	$20.3M	Sell	1,985,022 -397	-0%	-$4.32K	0.1%	185
2016 Q2	$25.9M	Sell	1,985,419 -3,706	-0.2%	-$48.6K	0.13%	154
2016 Q1	$21.9M	Buy	1,989,125 +31,595	+2%	+$281K	0.11%	192
2015 Q4	$18M	Buy	1,957,530 +113,502	+6%	+$950K	0.09%	217
2015 Q3	$12.8M	Sell	1,844,028 -94,800	-5%	-$812K	0.07%	246
2015 Q2	$19M	Sell	1,938,828 -54,831	-3%	-$499K	0.09%	202
2015 Q1	$17.7M	Sell	1,993,659 -31,295	-2%	-$249K	0.08%	219
2014 Q4	$17.7M	Buy	2,024,954 +33,244	+2%	+$269K	0.08%	217
2014 Q3	$13.7M	Buy	1,991,710 +760,575	+62%	+$4.56M	0.07%	243
2014 Q2	$6.48M	Buy	1,231,135 +236,029	+24%	+$1.15M	0.03%	332
2014 Q1	$4.53M	Sell	995,106 -222,714	-18%	-$1.08M	0.02%	345
2013 Q4	$6.13M	Sell	1,217,820 -131,018	-10%	-$630K	0.03%	311
2013 Q3	$6.84M	Buy	1,348,838 +754,675	+127%	+$4.2M	0.04%	278
2013 Q2	$2.95M	Buy	+594,163	New	+$2.83M	0.02%	350